Mulligan Richard 4
4 · Sana Biotechnology, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Mulligan Richard
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-03-02+200,000→ 200,000 totalExercise: $3.76Exp: 2033-03-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter.